References
Qu N, Zhang L, Ji HQ et al (2015) Risk factors for central compartment lymph node metastasis in papillary thyroid microcarcinoma: a meta-analysis. World J Surg. doi:10.1007/s00268-015-3108-3
Cooper DS, Doherty GM, Haugen BR et al (2009) Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 19:1167–1214
Hong YR, Yan CX, Mo GQ et al (2015) Conventional US, elastography, and contrast enhanced US features of papillary thyroid microcarcinoma predict central compartment lymph node metastases. Sci Rep 13(5):7748
Howell GM, Nikiforova MN, Carty SE et al (2013) BRAF V600E mutation independently predicts central compartment lymph node metastasis in patients with papillary thyroid cancer. Ann Surg Oncol 20(1):47–52
Alzahrani AS, Xing M (2013) Impact of lymph node metastases identified on central neck dissection (CND) on the recurrence of papillary thyroid cancer: potential role of BRAFV600E mutation in defining CND. Endocr Relat Cancer 20(1):13–22
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Coskun, A.K. The Significance of BRAF V600e Mutation and Preoperative Ultrasound for Central Compartment Lymph Node Metastasis in Papillary Thyroid Microcarcinoma. World J Surg 40, 759–760 (2016). https://doi.org/10.1007/s00268-015-3178-2
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00268-015-3178-2